Effects of Telemonitoring on the Outcome of Heart Failure Patients After an Incidence of Acute Decompensation (Medly-AID)
Heart Failure
About this trial
This is an interventional health services research trial for Heart Failure focused on measuring telemonitoring, smartphone application
Eligibility Criteria
Inclusion Criteria:
- Adults (18 years or older)
- Hospitalization for decompensated HF > 48 hours
- Patient speaks and reads English adequately to provide informed consent and understand the text prompts in the application (or has an informal caregiver who can translate for them)
- Ability to comply with using Medly (ex. able to stand on the weight scale, able to answer symptom questions, etc.)
Exclusion Criteria:
- Dementia or uncontrolled psychiatric illness
- Residents of long-term care facilities
- Terminal diagnosis of any health condition with a life expectancy < 1 year
- Patients who will require inpatient rehabilitation after discharge
- Participating in another clinical trial that may confound the results
Sites / Locations
- North York General Hospital
- Sunnybrook Health Sciences Centre
- Mount Sinai Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Telemonitoring (Medly)
Control
Medly is a smartphone application allows heart failure (HF) patients to measure and record their daily weight, blood pressure (BP), heart rate, and self-reported symptoms. This monitoring information is then transmitted wirelessly to a data server where an algorithm is used to generate an alert to a healthcare provider as necessary. The patient also receives an automated self-care message based on their measurements and reported symptoms.
Standard of care: Control groups will receive standard medical care when discharged from hospital, including discharge instructions, home medications as well as follow-up in a heart failure clinic or with a primary care doctor.